DeLorean has set up the reservation system for its upcoming Alpha5, the model they have been promising to send into production for quite a while. The reservation process might make some give up ...

DeLorean plans to build 4,000 Alpha5 EVs with a reservation system based on NFTs. Interested customers must purchase a $2,500 NFT to reserve their Alpha5 build slot. Final pricing and ...

Enter decentralized mesh hyperscalers: cloud networks that dynamically share idle resources, push computing closer to the source of data and enable localized processing. As the cloud evolves from ...

A judge has denied Tallahassee City Commissioner Jeremy Matlow's request to have his lawsuit against the Blueprint Intergovernmental Agency board reheard. Circuit Judge John Cooper threw out ...

Call of Duty: Black Ops 6 and Warzone players can unlock free weapon blueprints by pre-ordering, participating in beta testing, or linking their accounts. These blueprints offer preset attachments ...

PARIS and CAMBRIDGE, Mass., June 2, 2025 /PRNewswire/ -- Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic ...

Just five weeks later, Sanofi has made a deal few would describe as “bolt-on,” as it has bought out Massachusetts-based Blueprint Medicines for up to $9.5 billion. With the deal, Sanofi gains ...

Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare immunological diseases. Sanofi will pay $129 per share in cash for the US ...

The best mesh router overall is the Eero 6 Plus. It's a two-piece mesh system that checks many boxes: support for Wi-Fi 6, fast performance and a price tag of $225. Those specs translate to the ...

Three different mesh types were evaluated. Biologic meshes have properties similar to human tissues, whereas synthetic meshes are composed of artificial materials. The third type, long-acting ...

Paris and Cambridge, MA. June 2, 2025. Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a ...

Sanofi announced that it will buy pharma company Blueprint Medicines for $129 per share, making the deal worth more than $9 billion. Blueprint specializes in systemic mastocytosis and other ...